A 75-year-old male suffering from heart disease has a permanent pacemaker implanted. He has been taking warfarin and sotalol for chronic atrial fibrillation and atorvastatin for hyperlipidemia for several years. Since last year, his atrial fibrillation has been getting worse. Due to persistent episodes of atrial fibrillation, his provider decided to prescribe the anti-arrhythmic agent amiodarone to replace sotalol. Approximately two weeks later, the INR (a measure of how fast the blood clots, used for monitoring and determining the dose of warfarin) had increased to 4.8 (goal range is 2–3), indicating over-anticogualation. Discuss the following questions: Why did the INR increase above the normal range? What is the mechanism of action of the underlying drug-drug interaction? What were the potential adverse effects? What actions should the health care professional take in this situation? What overall counseling points would you give a patient on a narrow therapeutic index medication like warfarin?
[Verified Answer]: A 75-year-old male suffering from heart…
Need help with your Cardiovascular Disorders case study or NCLEX preparation? Connect with a verified Nursing expert now.